Advanced search
Publication Cover
Journal of Medical Economics Volume 26, 2023 - Issue 1
Submit an article Journal homepage
1,292
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness of nivolumab and ipilimumab versus pembrolizumab and axitinib in advanced renal cell carcinoma with intermediate or poor prognostic risk: a Brazilian private healthcare system perspective

Nishit Dhanjia Modeling & Meta-Analysis, OPEN Health, Oxford, UKView further author information
,
Tassia Cristina Decimonib Health Economics and Outcomes Research, Bristol Myers Squibb, São Paulo, SP, BrazilORCID Iconhttps://orcid.org/0000-0002-0999-9039View further author information
ORCID Icon,
Matthew T. D. Dyerc WW Health Economics and Outcomes Research, Bristol Myers Squibb, Uxbridge, UKCorrespondence[email protected]
View further author information
,
Jessica R. Mayc WW Health Economics and Outcomes Research, Bristol Myers Squibb, Uxbridge, UKORCID Iconhttps://orcid.org/0000-0003-0792-7936View further author information
ORCID Icon,
Gijs van de Weteringd Modeling & Meta-Analysis, OPEN Health, Rotterdam, NetherlandsView further author information
,
Svenja Petersohnd Modeling & Meta-Analysis, OPEN Health, Rotterdam, NetherlandsORCID Iconhttps://orcid.org/0000-0001-5058-7645View further author information
ORCID Icon,
Katharina Nickele Modeling & Meta-Analysis, OPEN Health, Berlin, GermanyView further author information
,
Amanda Silvaf Commercialization Intercon Medical, Medical and Regulatory Affairs, São Paulo, SP, BrazilView further author information
,
David Q. B. Munizg Hospital Sírio-Libanês, São Paulo, BrazilView further author information
&
Ana Paula Casagrande D. Oliveirab Health Economics and Outcomes Research, Bristol Myers Squibb, São Paulo, SP, BrazilView further author information
 show all
Pages 1108-1121 | Received 05 Jul 2023, Accepted 24 Aug 2023, Published online: 09 Sep 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.